UBcare. Co. Ltd Cash Flow Conversion Efficiency
UBcare. Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, UBcare. Co. Ltd (032620) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩184.89 Million ≈ $125.29K USD) by net assets (₩159.99 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of UBcare. Co. Ltd (2011–2025)
Cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. This chart illustrates how UBcare. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View UBcare. Co. Ltd share price for real-time trading data and today's change.
UBcare. Co. Ltd Cash Flow Conversion Ratio Explained
UBcare. Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
UBcare. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UBcare. Co. Ltd ranked by their cash flow conversion efficiency. Also see UBcare. Co. Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hennessy Capital Investment Corp VI
NASDAQ:HCVI
|
-0.019x |
|
Kreate Group Oyj
HE:KREATE
|
0.254x |
|
NIIT Limited
NSE:NIITLTD
|
-0.015x |
|
Viking Acquisition Corp. I
NYSE:VACI
|
-0.001x |
|
Bike24 Holding AG
F:BIKE
|
0.059x |
|
Softronic AB
ST:SOF-B
|
0.055x |
|
SOTKAMO SILVER AB NAM.
F:VSO
|
0.214x |
|
Arihant Capital Markets Limited
NSE:ARIHANTCAP
|
-0.250x |
Annual Cash Flow Conversion Efficiency for UBcare. Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. Review UBcare. Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩158.89 Billion ≈ $107.68 Million |
₩16.63 Billion ≈ $11.27 Million |
0.105x | +342.05% |
| 2024-12-31 | ₩99.22 Billion ≈ $67.24 Million |
₩2.35 Billion ≈ $1.59 Million |
0.024x | +7.93% |
| 2023-12-31 | ₩113.54 Billion ≈ $76.94 Million |
₩2.49 Billion ≈ $1.69 Million |
0.022x | -39.77% |
| 2022-12-31 | ₩116.70 Billion ≈ $79.09 Million |
₩4.25 Billion ≈ $2.88 Million |
0.036x | -45.93% |
| 2021-12-31 | ₩117.89 Billion ≈ $79.89 Million |
₩7.94 Billion ≈ $5.38 Million |
0.067x | -39.01% |
| 2020-12-31 | ₩106.52 Billion ≈ $72.19 Million |
₩11.76 Billion ≈ $7.97 Million |
0.110x | -3.89% |
| 2019-12-31 | ₩102.57 Billion ≈ $69.51 Million |
₩11.79 Billion ≈ $7.99 Million |
0.115x | +39.13% |
| 2018-12-31 | ₩101.66 Billion ≈ $68.90 Million |
₩8.40 Billion ≈ $5.69 Million |
0.083x | -58.86% |
| 2017-12-31 | ₩46.55 Billion ≈ $31.55 Million |
₩9.35 Billion ≈ $6.33 Million |
0.201x | +198.71% |
| 2016-12-31 | ₩46.56 Billion ≈ $31.55 Million |
₩3.13 Billion ≈ $2.12 Million |
0.067x | -60.94% |
| 2015-12-31 | ₩45.31 Billion ≈ $30.70 Million |
₩7.80 Billion ≈ $5.28 Million |
0.172x | +30.76% |
| 2014-12-31 | ₩39.49 Billion ≈ $26.76 Million |
₩5.20 Billion ≈ $3.52 Million |
0.132x | +4.66% |
| 2011-12-31 | ₩47.23 Billion ≈ $32.01 Million |
₩5.94 Billion ≈ $4.02 Million |
0.126x | -- |
About UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more